FDA Grants Breakthrough Device Designation for Quest’s Haystack MRD Test
The circulating tumor DNA test is designed to identify MRD-positive patients with stage II colorectal cancer who may benefit from adjuvant therapy.
Read More
Search Results for: liver disease
Quanterix Accelerator Laboratory Gains New York State Clinical Lab Permit
The CLIA-certified facility is now authorized to operate in all 50 states, expanding biomarker testing capabilities nationwide.
Read More
FDA Grants De Novo Authorization for AI-Powered Prostate Cancer Prognostic Software
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Read More
Dxcover Expands Leadership Team with Clinical and Commercial Experts
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Read More
DocVilla Integrates with AccuReference Medical Lab for Direct EHR Connectivity
The cloud-based EHR platform now offers real-time lab ordering and results delivery, eliminating the need for separate portals or fax-based communication.
Read More